Introduction: The authors review their experience in transoral laryngeal microsurgery (TLM) that they performed with two different CO2 laser devices from the same company, which were both equipped with a micromanipulator and digital scanner. Material and Methods: A total of 91 glottic and glotto-supraglottic cancers were treated during the years 2009–2016 and then analyzed in relation to the laser performances and the long-term oncologic results. Results: Laser devices proved to be very efficient and the UP mode was confirmed to be the best in terms of cutting precision and lowest thermal damage. Conclusions: CO2 laser TLM is the preferred option for the majority of small–medium size glottic and supraglottic cancers and may also be used for...
BACKGROUND: T3 laryngeal cancer encompasses heterogeneous lesions whose treatment is still debated....
PURPOSE OF REVIEW: Transoral laser microsurgery (TLM) is widely acknowledged to offer several advan...
BACKGROUND: T3 laryngeal cancer encompasses heterogeneous lesions whose treatment is still debated....
Background. The aim of the study was to evaluate the effectiveness of endoscopic CO2 laser microsurg...
Background. The aim of the study was to evaluate the effectiveness of endoscopic CO2 laser microsur...
Introduction Transoral laser microsurgery (TLM) has won territory in larynx oncology, establishing i...
Abstract: Background. The aim of the study was to evaluate the effectiveness of endoscopic CO2 laser...
Transoral laser microsurgery (TLM) is an emerging technique for the management of laryngeal and othe...
BACKGROUND: Transoral CO(2) laser surgery has been accepted as a valuable therapeutic option for...
BACKGROUND: Transoral CO(2) laser surgery has been accepted as a valuable therapeutic option for g...
Background. The aim of the study was to assess the effectiveness of CO2 laser endoscopic surgery in ...
Transoral CO 2 laser microsurgery is gaining ground at the expense of external approaches in the man...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Objective: Presently, widely employed treatment modalities for early glottic carcinoma include radia...
Early glottic squamous cell carcinoma (Tis–T1) is a highly treatable disease by any of the main trea...
BACKGROUND: T3 laryngeal cancer encompasses heterogeneous lesions whose treatment is still debated....
PURPOSE OF REVIEW: Transoral laser microsurgery (TLM) is widely acknowledged to offer several advan...
BACKGROUND: T3 laryngeal cancer encompasses heterogeneous lesions whose treatment is still debated....
Background. The aim of the study was to evaluate the effectiveness of endoscopic CO2 laser microsurg...
Background. The aim of the study was to evaluate the effectiveness of endoscopic CO2 laser microsur...
Introduction Transoral laser microsurgery (TLM) has won territory in larynx oncology, establishing i...
Abstract: Background. The aim of the study was to evaluate the effectiveness of endoscopic CO2 laser...
Transoral laser microsurgery (TLM) is an emerging technique for the management of laryngeal and othe...
BACKGROUND: Transoral CO(2) laser surgery has been accepted as a valuable therapeutic option for...
BACKGROUND: Transoral CO(2) laser surgery has been accepted as a valuable therapeutic option for g...
Background. The aim of the study was to assess the effectiveness of CO2 laser endoscopic surgery in ...
Transoral CO 2 laser microsurgery is gaining ground at the expense of external approaches in the man...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Objective: Presently, widely employed treatment modalities for early glottic carcinoma include radia...
Early glottic squamous cell carcinoma (Tis–T1) is a highly treatable disease by any of the main trea...
BACKGROUND: T3 laryngeal cancer encompasses heterogeneous lesions whose treatment is still debated....
PURPOSE OF REVIEW: Transoral laser microsurgery (TLM) is widely acknowledged to offer several advan...
BACKGROUND: T3 laryngeal cancer encompasses heterogeneous lesions whose treatment is still debated....